Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Jazz Pharmaceuticals Sings a Sweet Tune in Q2

TheMotleyFool

0 0

Jazz Pharmaceuticals Sings a Sweet Tune in Q2

It was music to investors' ears the last time Jazz Pharmaceuticals (NASDAQ: JAZZ) announced its quarterly results in May. Revenue was up 14% year over year with adjusted earnings jumping 17% higher.

Jazz announced its second-quarter results after the market closed on Tuesday. Here are the highlights from the drugmaker's quarterly update.

Image source: Getty Images.

Quelle Fool.com

Like: 0

JAZZ

Share